Scholars@Duke
Journal cover image

Why Dr. Robert Califf's Nomination for Commissioner of the Food and Drug Administration Is Good for Heart Failure Patients.

Publication ,  Journal Article
O'Connor, CM
Published in: JACC Heart Fail
January 2016
Published version (DOI) Link to item

Duke Scholars

Christopher Michael O'Connor
Author Christopher Michael O'Connor Medicine, Clinical Pharmacology
Altmetric Attention Stats
Dimensions Citation Stats

Published In

JACC Heart Fail

DOI

10.1016/j.jchf.2015.11.004

EISSN

2213-1787

Publication Date

January 2016

Volume

4

Issue

1

Start / End Page

90 / 91

Location

United States

Related Subject Headings

  • United States Food and Drug Administration
  • United States
  • Leadership
  • 3201 Cardiovascular medicine and haematology
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
O’Connor, C. M. (2016). Why Dr. Robert Califf's Nomination for Commissioner of the Food and Drug Administration Is Good for Heart Failure Patients. JACC Heart Fail, 4(1), 90–91. https://doi.org/10.1016/j.jchf.2015.11.004
O’Connor, Christopher M. “Why Dr. Robert Califf's Nomination for Commissioner of the Food and Drug Administration Is Good for Heart Failure Patients.” JACC Heart Fail 4, no. 1 (January 2016): 90–91. https://doi.org/10.1016/j.jchf.2015.11.004.
O’Connor, Christopher M. “Why Dr. Robert Califf's Nomination for Commissioner of the Food and Drug Administration Is Good for Heart Failure Patients.” JACC Heart Fail, vol. 4, no. 1, Jan. 2016, pp. 90–91. Pubmed, doi:10.1016/j.jchf.2015.11.004.
Journal cover image

Published In

JACC Heart Fail

DOI

10.1016/j.jchf.2015.11.004

EISSN

2213-1787

Publication Date

January 2016

Volume

4

Issue

1

Start / End Page

90 / 91

Location

United States

Related Subject Headings

  • United States Food and Drug Administration
  • United States
  • Leadership
  • 3201 Cardiovascular medicine and haematology
  • 1102 Cardiorespiratory Medicine and Haematology